CORP BRIEF: Duopharma Biotech, FGV, MSM Perlis and Rhone Ma

by TMR / graphic by MZUKRI MOHAMAD

Duopharma Biotech gives RM1m to Cerdik

DUOPHARMA Biotech Bhd has contributed RM1 million to the Cerdik programme, a national initiative in partnership with the Education Ministry and Finance Ministry, to provide 646 devices comprising laptops with data connectivity to students from low-income families. Announced in Budget 2021, Cerdik is a pioneering corporate social responsibility initiative, by the government-linked companies and government-linked investment companies (GLICs), to support lower-income families to better adjust to the new normal of online lessons, e-learning and other forms of remote teaching. “Indeed, as exemplified by the Cerdik initiative, closing the digital gap and promulgating digital learning are among critical catalytic moves that are required to build an essential talent platform, one that will help drive our nation’s sustainable growth into the global digital economy,” Duopharma Biotech group MD Leonard Ariff Abdul Shatar said in a statement yesterday. To date, close to 69,000 devices have been distributed by GLCs and GLICs to various state education departments, through Yayasan Hasanah, with the balance expected to be distributed in stages and completed by end-September 2021.

FGV, MSM Perlis agree to extend cut-off date

FGV Holdings Bhd, via its wholly owned unit FGV Integrated Farming Holdings Sdn Bhd, has mutually agreed to extend the cut-off date for the satisfaction or waiver with MSM Perlis Sdn Bhd. In a filing to Bursa Malaysia yesterday, the company said the date will be extended from Aug 31, 2021, to Sept 20, 2021. The group also mutually agreed with MSM to extend the date of completion from Sept 10, 2021 to no later than Sept 29, 2021, or such other dates as may be mutually agreed by both parties. Previously, FGV had proposed acquisition of the entire equity interest of MSM Perlis for an aggregate cash consideration of RM175 million, subject to adjustment for net debt and net working capital at completion date.

Rhone Ma appointed Citest’s test kit exclusive distributor in M’sia

RHONE Ma Holdings Bhd has been appointed as an exclusive distributor of Citest Diagnostics Inc’s Covid-19 Antigen Rapid Test Kit in Malaysia. Its indirect wholly owned subsidiary, APSN Healthcare and Diagnostics Sdn Bhd, has entered into a distributorship agreement with Citest to distribute the latter’s test kits in the country. Citest is an in vitro diagnostic company incorporated in Canada. Its products include various types of test kits in relation to women’s health, infectious disease, drug of abuse, oncology and cardiac markers.